lansoprazole CAS:103577-45-3

Lansoprazole is primarily used in the management of gastrointestinal disorders associated with excessive acid secretion. It is highly effective in providing relief from symptoms such as heartburn, regurgitation, and dyspepsia by inhibiting the proton pump responsible for gastric acid secretion. This medication is commonly prescribed for the treatment of GERD, erosive esophagitis, peptic ulcers (duodenal and gastric), and Zollinger-Ellison syndrome. Additionally, lansoprazole may be included as part of a combination therapy regimen to eradicate Helicobacter pylori infection, a common cause of peptic ulcers. It is available in various formulations, including delayed-release capsules, orally disintegrating tablets, and oral suspensions, allowing for flexibility in dosing and administration. Lansoprazole's efficacy and tolerability make it a cornerstone in the management of acid-related disorders, providing symptomatic relief and promoting healing of mucosal damage. However, like all medications, it may be associated with potential side effects and interactions, necessitating careful consideration and monitoring by healthcare professionals. Overall, lansoprazole plays a crucial role in improving the quality of life for individuals suffering from gastrointestinal conditions related to acid hypersecretion.